HIGH-DOSE VERSUS STANDARD FILGRASTIM SIGNIFICANTLY IMPROVES MOBILIZATION OF BLOOD PROGENITORS AND FACILITATES CD34+ IMMUNOSELECTION FOR ALLOGENEIC TRANSPLANTATION
M. Engelhardt et al., HIGH-DOSE VERSUS STANDARD FILGRASTIM SIGNIFICANTLY IMPROVES MOBILIZATION OF BLOOD PROGENITORS AND FACILITATES CD34+ IMMUNOSELECTION FOR ALLOGENEIC TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 664-664